相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanotechnology Solutions for Alzheimer's Disease: Advances in Research Tools, Diagnostic Methods and Therapeutic Agents
Amir Nazem et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Alternative Formulations, Delivery Methods, and Administration Options for Psychotropic Medications in Elderly Patients With Behavioral and Psychological Symptoms of Dementia
Russ S. Muramatsu et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2010)
Recent Advances in Transdermal Drug Delivery
Robhash Kusam Subedi et al.
ARCHIVES OF PHARMACAL RESEARCH (2010)
Preparation and Evaluation of Taste-Masked Donepezil Hydrochloride Orally Disintegrating Tablets
Yi-Dong Yan et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease
Guillaume Bastiat et al.
BIOMATERIALS (2010)
Effectiveness and Tolerability of High-Dose (23 mg/d) Versus Standard-Dose (10 mg/d) Donepezil in Moderate to Severe Alzheimer's Disease: A 24-Week, Randomized, Double-Blind Study
Martin R. Farlow et al.
CLINICAL THERAPEUTICS (2010)
Switching from Oral Cholinesterase Inhibitors to the Rivastigmine Transdermal Patch
C. Sadowsky et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease
Murat Emre et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
New Prospectives in the Delivery of Galantamine for Elderly Patients Using the IntelliDrug Intraoral Device: In Vivo Animal Studies
L. I. Giannola et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia
Taher Darreh-Shori et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease
Nazem Bassil et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials
C. H. Sadowsky et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease
G. T. Grossberg et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Super-short solid silicon microneedles for transdermal drug delivery applications
Li Wei-Ze et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Intranasal Delivery to the Central Nervous System: Mechanisms and Experimental Considerations
Shyeilla V. Dhuria et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Thinking Outside the Pillbox - Medication Adherence as a Priority for Health Care Reform
David M. Cutler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Review of Clinical Pharmacokinetics and Pharmacodynamics of Galantamine, a Reversible Acetylcholinesterase Inhibitor for the Treat-ment of Alzheimer's Disease, in Healthy Subjects and Patients
Fenglei Huang et al.
CURRENT CLINICAL PHARMACOLOGY (2010)
Development and optimization of a sublingual tablet formulation for physostigmine salicylate
Noushin Bolourchian et al.
ACTA PHARMACEUTICA (2009)
Alzheimer's disease treatment: Assessing caregiver preferences for mode of treatment delivery
Linda Abetz et al.
ADVANCES IN THERAPY (2009)
Safety and Tolerability of the Rivastigmine Patch Results of a 28-week Open-label Extension
George Grossberg et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Hepatitis With Cholestasis Caused by Rivastigmine Transdermal Patch
Nicola Mumoli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Alzheimer's disease in women
Michael C. Craig et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2009)
Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimer's Disease
Nazem Bassil et al.
CNS DRUGS (2009)
Persistence with Cholinesterase Inhibitor Therapy for Dementia An Observational Administrative Health Database Study
Nathan Herrmann et al.
DRUGS & AGING (2009)
Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review
A. Kurz et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Significant delivery of tacrine into the brain using magnetic chitosan microparticles for treating Alzheimer's disease
Barnabas Wilson et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
A study of rivastigmine liposomes for delivery into the brain through intranasal route
Karthik Arumugam et al.
ACTA PHARMACEUTICA (2008)
Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting
Viral V. Jogani et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2008)
One-week dose titration of extended release galantamine in patients with Alzheimer's disease
Douglas W. Scharre et al.
ALZHEIMERS & DEMENTIA (2008)
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
Barnabas Wilson et al.
BRAIN RESEARCH (2008)
Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease
Jiri Patocka et al.
CURRENT DRUG METABOLISM (2008)
Drug delivery from the oral cavity: focus on a novel mechatronic delivery device
Oliver A. Scholz et al.
DRUG DISCOVERY TODAY (2008)
Transdermal delivery of treatment for Alzheimer's disease
Agnes L. F. Chan et al.
DRUGS & AGING (2008)
Adherence to Medication in Patients with Dementia Predictors and Strategies for Improvement
Sonke Arlt et al.
DRUGS & AGING (2008)
Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting
Xiaomei Wang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles
Barnabas Wilson et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Current status and the future of buccal drug delivery systems
S. Indiran Pather et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Transdermal Delivery by Iontophoresis
Swati Rawat et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
In situ gelling hydrogels for pharmaceutical and biomedical applications
Sophie R. Van Tomme et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Pharmacokinetics and bioavailability of the novel rivastigmine transdermal patch versus rivastigmine oral solution in healthy elderly subjects
Gilbert Lefevre et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
A Nanoparticulate drug-delivery system for rivastigmine:: Physico-chemical and in vitro biological characterization
Ernanuela Fabiola Craparo et al.
MACROMOLECULAR BIOSCIENCE (2008)
Delivering drugs by the transdermal route: review and comment
T. Tanner et al.
SKIN RESEARCH AND TECHNOLOGY (2008)
In Situ-forming oleogel implant for rivastigmine delivery
Anda Vintiloiu et al.
PHARMACEUTICAL RESEARCH (2008)
Nose-to-brain delivery of tacrine
Viral V. Jogani et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Donepezil preserves cognition and global function in patients with severe Alzheimer disease
S. E. Black et al.
NEUROLOGY (2007)
Rationale for transdermal drug administration in Alzheimer disease
Wolfgang Oertel et al.
NEUROLOGY (2007)
Pharmacokinetic rationale for the rivastigmine patch
Jeffrey Cummings et al.
NEUROLOGY (2007)
A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease -: rivastigmine patch versus capsule
Bengt Winblad et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Donepezil: an update
Ben Seltzer
EXPERT OPINION ON PHARMACOTHERAPY (2007)
In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo
Alexis Kays Leonard et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Preclinical investigation of the topical administration of phenserine: Transdermal flux, cholinesterase inhibition, and cognitive efficacy
Tadanobu Utsuki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
In vitro and in vivo evaluation of donepezil-sustained release microparticles for the treatment of Alzheimer's disease
Pengcheng Zhang et al.
BIOMATERIALS (2007)
Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease
Roy W. Jones et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Rivastigmine transidermal patch: In the treatment of dementia of the Alzheimer's type
Lily P. H. Yang et al.
CNS DRUGS (2007)
Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance
Gang Liu et al.
NEUROSCIENCE LETTERS (2006)
Pharmacokinetic profile of a sustained-delivery system for physostigmine in rats
Donna Tan et al.
MATERIALS SCIENCE AND ENGINEERING B-SOLID STATE MATERIALS FOR ADVANCED TECHNOLOGY (2006)
Formulation and statistical optimization of novel double-incorporated PLA-PLGA microparticles within an alginate-pectinate platform for the delivery of nicotine
Neha Singh et al.
JOURNAL OF MICROENCAPSULATION (2006)
Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month study
F Dunbar et al.
CLINICAL THERAPEUTICS (2006)
Nanoparticle-mediated local and remote manipulation of protein aggregation
MJ Kogan et al.
NANO LETTERS (2006)
Transdermal treatment options for neurological disorders - Impact on the elderly
Lorenzo Priano et al.
DRUGS & AGING (2006)
Study on brain targeting of raltitrexed following intranasal administration in rats
DX Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Neuroscience nanotechnology: Progress, opportunities and challenges
GA Silva
NATURE REVIEWS NEUROSCIENCE (2006)
Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model
X Yue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Characterization and biocompatibility of organogels based on L-alanine for parenteral drug delivery implants
A Motulsky et al.
BIOMATERIALS (2005)
One-compound-multiple-targets strategy to combat Alzheimer's disease
HY Zhang
FEBS LETTERS (2005)
Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers
QY Zhao et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Development of a novel high-concentration galantamine formulation suitable for intranasal delivery
AK Leonard et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Transdermal estrogen patches for aggressive behavior in male patients with dementia: a randomized, controlled trial
KA Hall et al.
INTERNATIONAL PSYCHOGERIATRICS (2005)
Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents
U Westin et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation
JP Hing et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases
ZR Cui et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease
H Brodaty et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)
Functional evidence for P-glycoprotein at the nose-brain barrier
CL Graff et al.
PHARMACEUTICAL RESEARCH (2005)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
In situ forming parenteral drug delivery systems: an overview
CB Packhaeuser et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease
D Galasko et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration
RG Thorne et al.
NEUROSCIENCE (2004)
Alzheimer's disease pathogenesis and therapeutic interventions
MS Parihar et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2004)
Glutamate and the glutamate receptor system:: a target for drug action
S Bleich et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence
W Danysz et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility
E Fournier et al.
BIOMATERIALS (2003)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Alzheimer disease: Current concepts and emerging diagnostic and therapeutic strategies
CM Clark et al.
ANNALS OF INTERNAL MEDICINE (2003)
Caspase activation in the Alzheimer's disease brain: Tortuous and torturous
TT Rohn et al.
DRUG NEWS & PERSPECTIVES (2002)
Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated Aβ(1-42) injections in the rat
RL Richardson et al.
BRAIN RESEARCH (2002)
Studies for the emetic mechanisms of ipecac syrup (TJN-119) and its active components in ferrets: Involvement of 5-hydroxytryptamine receptors
M Hasegawa et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2002)
Transdermal iontophoresis of tacrine in vivo
T Kankkunen et al.
PHARMACEUTICAL RESEARCH (2002)
Nicotinic Treatment for Cognitive Dysfunction
E. D. Levin et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers
SK Min et al.
PSYCHOPHARMACOLOGY (2001)
Direct nose-brain transport of benzoylecgonine following intranasal administration in rats
HHS Chow et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
High-dose estradiol improves cognition for women with AD - Results of a randomized study
S Asthana et al.
NEUROLOGY (2001)
A systematic review of the associations between dose regimens and medication compliance
AJ Claxton et al.
CLINICAL THERAPEUTICS (2001)
Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage
XF Liu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)
Nasal administration of a physostigmine analogue (NXX-066) for Alzheimer's disease to rats
M Dahlin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease - Epidemiology and management
S Gauthier
DRUGS & AGING (2001)
Galantamine - A review of its use in Alzheimer's disease
LJ Scott et al.
DRUGS (2000)
Controlled transdermal iontophoresis by ion-exchange fiber
T Jaskari et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Transport of drugs from the nasal cavity to the central nervous system
L Illum
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2000)
Treating nondementia illnesses in patients with dementia
DJ Brauner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease - A randomized controlled trial
RI Mulnard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Estrogen for Alzheimer's disease in women - Randomized, double-blind, placebo-controlled trial
VW Henderson et al.
NEUROLOGY (2000)
分享论文
